NMDA-ANTAGONIST-PRODRUGS
European patent · EP4001272 · In force
Register entry
- Publication number
- EP4001272
- Application number
- EP21196371
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 30, 2014
- Published
- May 25, 2022
- Granted
- Nov 13, 2024
- Protection ends at the latest
- Oct 29, 2034
- Next annual fee due
- Oct 31, 2026
- IPC classes
- C07D 401/14 (2006.01)C07D 401/12 (2006.01)C07D 213/40 (2006.01)A61K 31/4402 (2006.01)A61K 31/4439 (2006.01)C07K 5/068 (2006.01)C07K 5/078 (2006.01)C07K 5/065 (2006.01)C07K 5/072 (2006.01)C07K 5/062 (2006.01)A61P 25/24 (2006.01)
- Priority
- US 201361899903 P 05.11.2013
- Divided from
- EP19166031
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2025
Change
Published in Swissreg on 01.11.2025
- Sep 24, 2025
Change
Published in Swissreg on 24.09.2025
- Jan 7, 2025
Agent entered
- Representative
- Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 07.01.2025
- Nov 13, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 13.11.2024
Parties
Inventor
NORDVALL, Gunnar
Macclesfield, SK10 4TG, GB
HÖGDIN, Katharina
Macclesfield, SK10 4TG, GB
MALMBORG, Per Jonas
Macclesfield, SK10 4TG, GB
KERS, Annika
Macclesfield, SK10 4TG, GB
WEIGELT, Dirk
Macclesfield, SK10 4TG, GB
BERNSTEIN, Peter
Waltham, 02451, US
QUIRK, Michael
Waltham, 02451, US
BALESTRA, Michael
Waltham, 02451, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.